Cell reprogramming is a biotechnology process that involves the conversion of a cell from one type to another. It is used to create induced pluripotent stem cells (iPSCs) from adult cells, which can then be used to study diseases, develop new treatments, and create personalized medicine. Cell reprogramming is also used to create cell models of diseases, which can be used to study the underlying mechanisms of the disease and develop new therapies. Additionally, cell reprogramming can be used to create cell-based therapies, such as gene therapy, which can be used to treat genetic diseases. Cell reprogramming is a rapidly growing field, with many companies investing in the technology. Some of the companies in the market include Ginkgo Bioworks, Cellular Dynamics International, Fate Therapeutics, and Pluristem Therapeutics. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.